Carl Graham

6.1k total citations
23 papers, 540 citations indexed

About

Carl Graham is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Carl Graham has authored 23 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Carl Graham's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (10 papers) and Musculoskeletal pain and rehabilitation (3 papers). Carl Graham is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (10 papers) and Musculoskeletal pain and rehabilitation (3 papers). Carl Graham collaborates with scholars based in United Kingdom, Australia and Uganda. Carl Graham's co-authors include Katie J. Doores, Michael H. Malim, Jeffrey Seow, Stuart J. D. Neil, Julia Kenny, Michael J. Carter, Shane M. Tibby, Manu Shankar‐Hari, Matthew Fish and A.R. Jennings and has published in prestigious journals such as Nature Medicine, Nature Communications and Blood.

In The Last Decade

Carl Graham

22 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Graham United Kingdom 12 277 186 79 61 58 23 540
Gilbert T. Chua Hong Kong 14 287 1.0× 87 0.5× 57 0.7× 72 1.2× 20 0.3× 52 676
Danielle Eddy United Kingdom 6 689 2.5× 69 0.4× 68 0.9× 68 1.1× 8 0.1× 7 904
Kamleshun Ramphul China 13 130 0.5× 66 0.4× 39 0.5× 27 0.4× 13 0.2× 80 453
Rolf Schlößer Germany 14 111 0.4× 125 0.7× 35 0.4× 14 0.2× 13 0.2× 53 662
Roxane Schaub France 13 97 0.4× 180 1.0× 59 0.7× 33 0.5× 21 0.4× 30 551
Wei Li Adeline Koay United States 8 300 1.1× 117 0.6× 93 1.2× 16 0.3× 4 0.1× 22 493
Thoyaja Koritala United States 11 198 0.7× 53 0.3× 60 0.8× 29 0.5× 5 0.1× 37 436
Claire Broderick United Kingdom 9 162 0.6× 239 1.3× 41 0.5× 22 0.4× 3 0.1× 13 441
Hanin I. Daas Qatar 7 332 1.2× 36 0.2× 67 0.8× 19 0.3× 8 0.1× 12 595
Danna Moustafa United States 8 201 0.7× 114 0.6× 23 0.3× 56 0.9× 160 2.8× 17 652

Countries citing papers authored by Carl Graham

Since Specialization
Citations

This map shows the geographic impact of Carl Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Graham more than expected).

Fields of papers citing papers by Carl Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Graham. The network helps show where Carl Graham may publish in the future.

Co-authorship network of co-authors of Carl Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Graham. A scholar is included among the top collaborators of Carl Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Graham. Carl Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katende, Joseph Ssebwana, Carl Graham, Jeffrey Seow, et al.. (2025). Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort. Vaccines. 13(2). 143–143. 1 indexed citations
2.
Tam, Jerry C H, Jeffrey Seow, Carl Graham, et al.. (2025). Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses. Cell Reports. 44(7). 116000–116000.
3.
Katende, Joseph Ssebwana, Carl Graham, Jeffrey Seow, et al.. (2025). Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison. Vaccines. 13(4). 336–336. 1 indexed citations
4.
Pickering, Suzanne, Harry Wilson, Marianne Perera, et al.. (2024). Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages. Nature Communications. 15(1). 10764–10764. 1 indexed citations
5.
Snell, Luke B., Jerry C H Tam, Carl Graham, et al.. (2023). Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals. PubMed. 4(1). iqac012–iqac012. 1 indexed citations
6.
Seow, Jeffrey, Carl Graham, Thomas Lechmere, et al.. (2022). ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants. Cell Reports. 39(5). 110757–110757. 11 indexed citations
7.
Graham, Carl, Thomas Lechmere, Jeffrey Seow, et al.. (2022). The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern. PLoS Pathogens. 18(10). e1010882–e1010882. 5 indexed citations
8.
Seow, Jeffrey, Hataf Khan, Annachiara Rosa, et al.. (2022). A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination. Cell Reports. 40(8). 111276–111276. 23 indexed citations
9.
Abdul-Jawad, Sultan, Richard Beatson, Thomas Lechmere, et al.. (2022). BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes. Haematologica. 107(5). 1181–1184. 5 indexed citations
10.
Dicks, Matthew D. J., Louisa Rose, Rebecca A. Russell, et al.. (2022). Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2. Molecular Therapy. 30(12). 3639–3657. 16 indexed citations
11.
Harrington, Patrick, Hugues de Lavallade, Katie J. Doores, et al.. (2021). Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms. Leukemia. 35(12). 3573–3577. 31 indexed citations
12.
Khan, Hataf, Helena Winstone, Jose M. Jiménez-Guardeño, et al.. (2021). TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathogens. 17(11). e1009820–e1009820. 20 indexed citations
13.
Harrington, Patrick, Katie J. Doores, Chandan Saha, et al.. (2021). Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients. Blood. 138(Supplement 1). 3920–3920. 1 indexed citations
14.
Carter, Michael J., Matthew Fish, A.R. Jennings, et al.. (2020). Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nature Medicine. 26(11). 1701–1707. 258 indexed citations
15.
Lauder, Kate, Coralie Valle, Bruno Canard, et al.. (2019). Design, Synthesis and Discovery of N,N’‐Carbazoyl‐aryl‐urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication. ChemMedChem. 15(4). 385–390. 18 indexed citations
16.
Parkitny, Luke, Benedict M. Wand, Carl Graham, John Quintner, & G. Lorimer Moseley. (2016). Interdisciplinary Management of Complex Regional Pain Syndrome of the Face. Physical Therapy. 96(7). 1067–1073. 8 indexed citations
17.
Graham, Carl, et al.. (2013). Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients. The Journal of the Royal College of Physicians of Edinburgh. 43(1). 15–23. 27 indexed citations
18.
Davies, Stephanie, John Quintner, Richard Parsons, et al.. (2010). Preclinic Group Education Sessions Reduce Waiting Times and Costs at Public Pain Medicine Units. Pain Medicine. 12(1). 59–71. 60 indexed citations
19.
Graham, Carl, et al.. (2004). Managing chronic pain through cognitive change and multidisciplinary treatment program. Australian Psychologist. 39(3). 201–207. 13 indexed citations
20.
Laurence, M., et al.. (1965). Prophylaxis against tetanus: An investigation into efficiency of a method. Journal of Clinical Pathology. 18(1). 23–26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilbert T. Chua Breakdown of academic impact, for papers by Danielle Eddy Breakdown of academic impact, for papers by Kamleshun Ramphul Breakdown of academic impact, for papers by Rolf Schlößer Breakdown of academic impact, for papers by Roxane Schaub Breakdown of academic impact, for papers by Wei Li Adeline Koay Breakdown of academic impact, for papers by Thoyaja Koritala Breakdown of academic impact, for papers by Claire Broderick Breakdown of academic impact, for papers by Hanin I. Daas Breakdown of academic impact, for papers by Danna Moustafa
Rankless by CCL
2026